Solid-State Study of the Structure, Dynamics, and Thermal Processes of Safinamide Mesylate—A New Generation Drug for the Treatment of Neurodegenerative Diseases

[Image: see text] Safinamide mesylate (SM), the pure active pharmaceutical ingredient (API) recently used in Parkinson disease treatment, recrystallized employing water–ethanol mixture of solvents (vol/vol 1:9) gives a different crystallographic form compared to SM in Xadago tablets. Pure SM crystal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlak, Tomasz, Oszajca, Marcin, Szczesio, Małgorzata, Potrzebowski, Marek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728732/
https://www.ncbi.nlm.nih.gov/pubmed/34856803
http://dx.doi.org/10.1021/acs.molpharmaceut.1c00779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728732/
https://www.ncbi.nlm.nih.gov/pubmed/34856803
http://dx.doi.org/10.1021/acs.molpharmaceut.1c00779

Ejemplares similares